High-Potent Oral Solid Dosage Contract Manufacturing Sector

Future Market Insights

High-Potent Oral Solid Dosage Contract Manufacturing Market

Key Insight

Tablets represent 46.5% of the dosage form category and fluid bed granulation accounts for 34.2% of formulation technology demand in 2025. The high-potent oral solid dosage contract manufacturing market was valued at USD 6.59 billion in 2025 and is forecast to post an 8.8% CAGR between 2025 and 2035.

June 11, 2025

Anurag Sharma

250 Pages

Cite this Report

High-Potent Oral Solid Dosage Contract Manufacturing Market

https://www.futuremarketinsights.com/reports/high-potent-oral-solid-dosage-contract-manufacturing-market

License

Buy Now

Summary ToC Companies

Key Players

Catalent Inc
CordenPharma International
Next pharma
PCI
Patheon Inc
The Vanguard Group
Piramal Pharma Solutions

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

High-Potent Oral Solid Dosage Contract Manufacturing Market

Key Players

Similar Industry Reports